UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 8, 2024

Accession Number:	0001193125-24-088114
Submission Type:	POS AM
CIK: 0001426332 Company Name: NGM BIOPHARMACEUTICALS INC File Number: 333-272509